In the News / Politics

States Expand Access to Naloxone

By: Svetlana Akbasheva, Staff Editor - Naloxone (Narcan®) is a rapid-acting, potentially life-saving drug for acute opioid overdose. An opioid…

11 years ago

Novel Anticoagulant Approved For Use in Embolism Prevention

By: Maryam Ahmed and Lyudmila Krivovyaz, Pharm.D Candidates, c/o 2016 - Each year, more than 795,000 Americans suffer from a…

11 years ago

New Therapeutic Options for IBS-D

By: Benedette Cuffari, B.S. of Toxicology Candidate 2016 - Affecting 10%-15% of the population in Western countries, irritable bowel syndrome…

11 years ago

Idiopathic Pulmonary Fibrosis: Treating a Mystery

By: Svetlana Akbasheva, Section Editor - Idiopathic pulmonary fibrosis (IPF) is a devastating condition in which the lungs become thick…

11 years ago

Even the FDA follows Kim!

By: Nancy Simon, PharmD Candidate 2016 - Many of you may have seen Kim Kardashian West’s Instagram posts – most…

11 years ago

Probiotics as a possible treatment antibiotic-associated diarrhea in the ICU

By: Holly Sokol, PharmD Candidate 2020 - Antibiotic-associated diarrhea (AAD) can occur due to antibiotics changing the elements of the…

11 years ago

New Treatment Option for Diabetic Retinopathy

By: Sylva Ohanian, Staff Writer - The FDA recently approved aflibercept (Eylea®) injection for the treatment of diabetic retinopathy (DR)…

11 years ago

Cytisine: Another Option for Smoking Cessation

By: Andrew Leong, Staff Writer - Quitting smoking greatly reduces the risk of many diseases such as lung cancer, coronary…

11 years ago

Aripiprazole (Abilify®) Approved

By: Sang Hyo Kim, Section Editor - On April 28, 2015, the U.S. Food and Drug Administration approved aripiprazole, the…

11 years ago

FDA Approves First Tissue Adhesive for Internal Use

By: Azia Tariq, Section Editor - The U.S. Food and Drug Administration (FDA) has approved TissuGlu®, the first tissue adhesive…

11 years ago